Ghofrani HA;Galiè N;Grimminger F;Grünig E;Humbert M;Jing ZC;Keogh AM;Langleben D;Kilama MO;Fritsch A;Neuser D;Rubin LJ;PATENT-1 Study Group, Riociguat for the treatment of pulmonary arterial hypertension., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2013, 369, pp. 330 - 340 [Scientific article]
Cantoni S;Galletti M;Zambelli F;Valente S;Ponti F;Tassinari R;Pasquinelli G;Galiè N;Ventura C, Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition., «THE FEBS JOURNAL», 2013, 280, pp. 2042 - 2055 [Scientific article]
G. Coghlan;A. Torbicki;N. Galie;L. Rubin;L. Perchenet;G. Simonneau, S47 Effect of macitentan on haemodynamics in patients with pulmonary arterial hypertension: results from the long-term, randomised, placebo-controlled SERAPHIN trial, «THORAX», 2013, 68, pp. A26 - A26 [Abstract]
Nazzareno Galiè;Gerald Simonneau, The Fifth World Symposium on Pulmonary Hypertension, «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2013, 62, pp. 1 - 3 [Scientific article]
Nazzareno Galiè;Paul A. Corris;Adaani Frost;Reda E. Girgis;John Granton;Zhi Cheng Jing;Walter Klepetko;Michael D. McGoon;Vallerie V. McLaughlin;Ioana R. Preston;Lewis J. Rubin;Julio Sandoval;Werner Seeger;Anne Keogh, Updated Treatment Algorithm of Pulmonary Arterial Hypertension, «JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY», 2013, 62, pp. D60 - D72 [Scientific article]
Beghetti M; Galiè N; Bonnet D, Can "inoperable" congenital heart defects become operable in patients with pulmonary arterial hypertension? Dream or reality?, «CONGENITAL HEART DISEASE», 2012, 7, pp. 3 - 11 [Scientific article]
Nazzareno Galiè; Alessandra Manes; Massimiliano Palazzini, Current medical therapies in pulmonary arterial hypertension, in: Pulmonary Hypertension, Sheffiled, European Respiratory Society, 2012, pp. 26 - 41 [Chapter or essay]
De Luca F; Modolon C; Buia F; Attinà D; Fughelli P; Bacchi Reggiani ML; Galiè N; Zompatori M, Densitometric CT evaluation of acute and chronic thromboembolic filling defects of the pulmonary arteries before and after contrast injection = Valutazione densitometrica dei difetti di riempimento tromboembolici acuti e cronici delle arterie polmonari prima e dopo somministrazione di mezzo di contrasto, «LA RADIOLOGIA MEDICA», 2012, 117, pp. 979 - 991 [Scientific article]
Rossi A.; Attinà D.; Borgonovi A.; Buia F.; De Luca F.; Guidalotti PL.; Fughelli P.; Galiè N.; Zompatori M., Evaluation of mosaic pattern areas in HRCT with Min-IP reconstructions in patients with pulmonary hypertension: could this evaluation replace lung perfusion scintigraphy?, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. E1 - E6 [Scientific article]
Russo V; Zompatori M; Galiè N, Extensive right pulmonary artery dissection in a young patient with chronic pulmonary hypertension, «HEART», 2012, 98, pp. 264 - 266 [Scientific article]
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galie' N, Genere femminile e ipertensione arteriosa polmonare: una relazione complessa
Female gender and pulmonary arterial hypertension: a complex relationship, «GIORNALE ITALIANO DI CARDIOLOGIA», 2012, 13, pp. 448 - 460 [Scientific article]
Galié N; Hoeper MM; Humbert M; Torbicki A; Vachiery JL; Barbera JA; Beghetti M; Corris P; Gaine S; Gibbs JS; Gomez-Sanchez MA; Jondeau G; Klepetko W; Opitz C; Peacock A; Rubin L; Zellweger M; Simonneau G; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; McGregor K; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P., Guidelines for the diagnosis and treatment of pulmonary hypertension
Orientações para o diagnóstico e tratamento da hipertensão pulmonar, «REVISTA PORTUGUESA DE CARDIOLOGIA», 2012, 31, pp. 71 - 115 [Scientific article]
Modolon C; Attinà D; Buia F; De Luca F; Fughelli P; Bacchi Reggiani ML; Palazzini M; Manes A; Leci E; Galiè N; Zompatori M, Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients, «EUROPEAN RADIOLOGY», 2012, 22, pp. 1059 - 1066 [Scientific article]
Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N, Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial, «CHEST», 2012, 142, pp. 1383 - 1390 [Scientific article]
Simonneau G; Torbicki A; Hoeper MM; Delcroix M; Karlócai K; Galiè N; Degano B; Bonderman D; Kurzyna M; Efficace M; Giorgino R; Lang IM, Selexipag, an oral, selective IP receptor agonist for the treatment of pulmonary arterial hypertension, «EUROPEAN RESPIRATORY JOURNAL», 2012, 40, pp. 874 - 880 [Scientific article]
